Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biocompatibility of Citrate vs Heparin in Plasmapheresis
NCT05191290Phase 4Completed
- Sponsor
- University Medical Centre Ljubljana
- Start
- Jan 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of trisodium citrate in immune system diseases, sponsored by University Medical Centre Ljubljana. Started Jan 2022; status: completed.
02
Drugs
trisodium citrate
03
Conditions
immune system diseases
Beyond the preview
Go deeper on NCT05191290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05191290.